Skip to main content
MedPathMedPath Home
Clinical Trials/ISRCTN13659155
ISRCTN13659155
Completed
未知

Fluid hydration to prevent post-endoscopic retrograde cholangiopancreatography pancreatitis

Radboud University Medical Center0 sites826 target enrollmentMay 18, 2015
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Radboud University Medical Center
Enrollment
826
Status
Completed
Last Updated
5 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

2018 protocol in: https://www.ncbi.nlm.nih.gov/pubmed/29606135 2021 results in https://pubmed.ncbi.nlm.nih.gov/33740415/ (added 22/03/2021)

Registry
who.int
Start Date
May 18, 2015
End Date
December 3, 2019
Last Updated
5 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • •1\. Requiring ERCP
  • •2\. Between 18 and 85 years of age
  • •3\. Signed informed consent

Exclusion Criteria

  • •1\. Allergy to NSAIDs or other contraindications
  • •2\. Ongoing acute pancreatitis
  • •3\. Ongoing hypotension, including those with sepsis
  • •4\. Cardiac insufficiency (CI, \>NYHA Class I heart failure)
  • •5\. Renal insufficiency (RI, creatinin clearance \<40ml/min)
  • •6\. Active ulcer disease
  • •7\. Severe liver dysfunction: liver cirrhosis and ascites
  • •8\. Respiratory insufficiency (pO2\<60mmHg or 90% despite FiO2 of 30% or requiring mechanical ventilation)
  • •9\. Pregnancy
  • •10\. Hyponatremia (Na\+ levels \< 130mmol/l)

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
Fluid hydration to prevent post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis: the FLUYT-prevent trial. a multicenter randomized controlled superiority trial.;Pancreatic duct stent placement to prevent post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis in patients with unintended PD-wire cannulation: a multicenter prospective cohortpost-ERCP pancreatitisinflammation of the pancreas following ERCP10017969
NL-OMON54543Sint Antonius Ziekenhuis1,108
Active, not recruiting
Phase 1
intravenous fluid administration to prevent pancreatic inflammation following endoscopic bile duct examination.Patients with choledocholithiasisTherapeutic area: Diseases [C] - Digestive System Diseases [C06]
EUCTR2015-000829-37-NLRadboud University Medical Center826
Recruiting
Not Applicable
IV Fluids and Post-ERCP PancreatitisERCP
NCT05211206University of Calgary13,000
Not yet recruiting
Not Applicable
Tailored hydration for the prevention of post-ERCP(endoscopic retrograde cholangiopancreatography) pancreatitisDiseases of the digestive system
KCT0003196Chonnam National University Hospital350
Completed
Not Applicable
Tailored Hydration for the Prevention of Post-ERCP PancreatitisCholangiopancreatography, Endoscopic RetrogradePancreatitis
NCT03561441Chonnam National University Hospital350